Pacific Edge Limited (NZX: PEB) Concludes Commercial Agreement with Facey Medical Group

Wednesday 31st March 2021

Cancer diagnostics company, Pacific Edge Limited has concluded a commercial agreement with Facey Medical Group, a physician owned medical group in California. The agreement covers the use of Cxbladder Detect and Cxbladder Monitor for Facey Medical Group patients.

Facey Medical Group is a multi-specialty medical group with over 180 physicians providing care to more than 170,000 patients in the North & East regions of Los Angeles & Ventura Counties in California. This makes it similar in size to the Mid-Central District Health Board in New Zealand. Facey Medical Group is also one of six California physician groups affiliated with, or owned by Providence Health & Services, one of the largest health systems in the Western United States.

CEO of Pacific Edge, David Darling, said: “Physician owned organisations such as the Facey Medical Group are an important customer group for Pacific Edge as we continue to expand the adoption and commercial use of Cxbladder in the US. We were approached by the Group following a number of the urologists utilising our products and we are pleased to move into a formal commercial relationship with them. Whilst test volumes are not expected to be large compared to healthcare organisations such as Kaiser Permanente, this agreement demonstrates the ongoing commercial adoption of Cxbladder in the US as we continue to position Cxbladder as the preferred diagnostic test for urologists evaluating patients for bladder cancer.”

Please see the link below for details:

PEB Concludes Commercial Agreement with Facey Medical Group in US

Source: Pacific Edge Limited

Comments from our readers

No comments yet